Clinical Trial Update: A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase Ib/II clinical study evaluating AK112 alone or with AK119 in pMMR/MSS colorectal cancer is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• AK112
• AK119

Snippet

Sponsor: Akeso | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING